Argobio and GeneCode Partner on Parkinson's Disease in Argobio's First Announced Research Agreement
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Neurotrophic Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Global Gene and Cell Therapies Targeting CNS Disorders Market 2021-2026 Featuring Emerging Drugs - NurOwn (BrainStorm Cell Therapeutics) & Neuro-Cells (Neuroplast) May 26, 2021 06:18 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com's offering. This 'Gene and Cell Therapies targeting CNS Disorders - Market Insights and Market Forecast - 2026' report delivers an in-depth understanding of the market trends of Gene and Cell Therapies targeting CNS Disorders in in the United States, EU5 (Germany, Spain, Ita...